Index Ventures, the global high tech venture capitalist, has appointed Dr
Kevin Johnson
as a life sciences partner to enhance its push into developing asset-centric investment strategy. Dr Johnson, who was both a venture adviser and CEO of ...
The Japanese government is to provide a multi-million dollar subsidy to the country's largest pharma company for the development of cell cultured vaccines for pandemic influenza.
Following an application for the support, Takeda has been notified ...
Ranbaxy Laboratories has opened its second manufacturing facility in South Africa at Roodepoort, Johannesburg, at an investment of $30 million.
It will manufacture a range of products including analgesics, cold, cough and flu preparations, ...
TiGenix, the Belgium based biotech that spunout its drug discovery activities last week, is focused on becoming a development and marketing company, its CEO
Gil Beyen
told Scrip.
The company spun out its drug discovery activities into new company ...
Meda of Sweden is to acquire the US speciality pharma company Alaven Pharmaceutical to enhance its US marketing capabilities and expand its therapeutic focus to include both gastroenterology and women's health, areas it already operates in outside ...
